Consortium established to support ICH M7 compliance
An industry work-group comprising of toxicologists, pharmaceutical companies and data experts plans to unveil the early results of a data sharing project...
List view / Grid view
An industry work-group comprising of toxicologists, pharmaceutical companies and data experts plans to unveil the early results of a data sharing project...
9 July 2012 | By European Medicines Agency (EMA)
The EMA has been notified by Sanofi-aventis of its decision to withdraw its marketing authorisation application for Mulsevo...
17 May 2011 | By Glenmark Pharmaceuticals
Sanofi to develop molecule for Crohn’s Disease & other anti-inflammatory conditions...
11 May 2011 | By Fleming Europe
Network with c-level industry leaders from AstraZeneca, Sanofi Aventis, Roche, Novartis, Baxter, Pfizer & Abbott...
5 May 2011 | By Sanofi-Aventis
Sanofi-aventis and MMV announced that they have signed an alliance agreement...
8 April 2011 | By Sanofi-Aventis
Sanofi-aventis has announced that it has completed its acquisition of Genzyme Corporation...
28 March 2011 | By Sanofi-aventis UK
Sanofi-aventis has signalled a strengthening of its support for patient groups in the UK...
23 March 2011 | By Sanofi-aventis
Sanofi-aventis announced the signing of a cooperation agreement between Fovea Pharmaceuticals & the Vision Institute...
11 March 2011 | By Sanofi-aventis
Sanofi-aventis is pleased to announce the appointment of Dr. Richard Klausner to Chairman of the SDSAC, effective March 1...